*February 2025*
Diagnosed with lung cancer at just 39 years old, EGFR Resisters co-founder Jill Feldman recounts how her advocacy efforts before her diagnosis prepared her for the battle ahead. Losing both parents and other close family members to lung cancer, Jill feared for her own children and worked tirelessly to ensure a different outcome. In this cancer vlog, Jill discusses advancements in lung cancer research and treatment that gave her hope and extended her life far beyond her family’s history. Watch Jill’s entire story here.
